Kevin Strange, Ph.D.

Co-founder and CEO, MSI-1436 co-inventor

Dr. Strange is an internationally recognized biomedical scientist, scientific leader, entrepreneur, and pioneer in the discovery and development of drugs for regenerative medicine. His research has been funded for more than 25 years by the National Institutes of Health, Department of Defense, and numerous private foundations. Dr. Strange is known for leading by example and doing what’s best, no matter the odds or expectations.

Voot Yin, Ph.D.

Co-founder and Chief Scientific Officer, MSI-1436 co-inventor

Dr. Yin is internationally recognized as an expert in regenerative medicine and biology and has extensive expertise in heart and limb regeneration. He developed the adult zebrafish model as a novel platform to screen for small molecules that activate tissue repair and regenerative processes. Dr. Yin’s research has been funded by the National Institutes of Health, the American Heart Association, and the Department of Defense.

Michael Zasloff, M.D., Ph.D.

Senior Scientific Advisor, MSI-1436 co-inventor

Dr. Zasloff is an internationally recognized biomedical scientist and entrepreneur. He was one of the first people to describe the existence of natural antimicrobial compounds that are produced by animals to fight infection. Dr. Zasloff has been awarded over 40 U.S. and international patents and has launched and participated in multiple commercial ventures aimed at bringing bench discoveries to the clinic. He has extensive experience with clinical trials and the FDA approval process.